As a valued PathGroup partner, we wanted to inform you that starting November 1, 2017, notification/prior authorization will be required for certain genetic and molecular lab tests for certain UnitedHealthcare Commercial benefit plans. Ordering providers will now need to complete the prior authorization process online at the UnitedHealthcare Link Portal or over the phone.

PathGroup will be unable to complete the notification/prior authorization process for our healthcare providers. This new requirement impacts not only PathGroup, but all laboratories offering genetic and molecular based tests.

For more information,CLICK HERE